Can-Fite BioPharma Ltd.

CANF chart

Can-Fite BioPharma Ltd. news

• Can-Fite Reports Ten-Year Survival Milestone in Advanced Liver Cancer Study

  TipRanks · Nov 9, 7:33 AM EST

• An advanced liver cancer patient remains cancer-free after Can-Fite (CANF)'s trial.

  Stock Titan · Nov 9, 7:01 AM EST

• Can-Fite Reports Ten-Year Survival Milestone for Advanced Liver Cancer Patient from Phase II Namodenoson Study

  Yahoo Finance · Nov 9, 7:00 AM EST

• A woman with advanced liver cancer remains cancer-free 10 years later

  Stock Titan · Nov 9, 7:00 AM EST

• Can-Fite BioPharma Ltd. (CANF) Seasonal returns chart

  Yahoo Finance UK · Nov 6, 3:59 PM EST

• Can-Fite BioPharma to seek partnerships at BIO-Europe 2026

  StreetInsider · Nov 6, 7:27 AM EST

• Can-Fite to Pursue Global Licensing and Strategic

  GlobeNewswire · Nov 6, 7:23 AM EST

• Can-Fite to Pursue Global Licensing and Strategic Partnerships at BIO-Europe 2026 Following Recent Clinical and Intellectual Property Milestones

  Yahoo Finance · Nov 6, 7:23 AM EST

• Can-Fite Announces Eurasian Patent Allowance Supporting Piclidenoson Development and Commercialization in Lowe Syndrome

  Yahoo Finance · Nov 2, 7:00 AM EST

• Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026

  Yahoo Finance · Oct 26, 7:00 AM EDT

• Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation

  Yahoo Finance · Sep 9, 7:00 AM EDT

• Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

  Yahoo Finance · Sep 8, 8:20 AM EDT

Can-Fite BioPharma Ltd. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-11-09
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-11-02
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-26
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-09
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-08
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-03
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-02
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-02
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-17
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-12
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-03
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-20

About Can-Fite BioPharma Ltd.

Ticker

CANF (NYSE)

Industry

Pharmaceutical Preparations

Headquarters

Ramat Gan, Israel

Incorporated in

Israel

Fiscal year end

December 31

SEC CIK

1536196

Frequently asked questions